Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Life & Style How to mitigate the health disaster of air pollution - can the successful Vietnamese Covid response teach us some lessons?